Advanced Therapies

Paris
#Advanced Therapies #Cell and gene therapy #ISCT #Regulatory

ISCT 2023 key trends: regulatory changes 

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. The ISCT 2023 Annual Meeting took place in Paris, France… Read More

#Exclusive Content #Regulatory

Innovation
#Advanced Therapies #Animal models #Autoimmune disease #Cell and gene therapy #Data #Genetics / genomics #Immunology #Pharma

New podcast on animal genomics, immunology and CGTs

This is the latest episode of the free DDW narrated podcast, “What’s at the forefront of innovation?” It covers three articles written for the for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Can animal genomics help find… Read More

#News

Lipid nanoparticle mRNA vaccine
#Advanced Therapies #Cell and gene therapy #Moderna #mRNA #Phase II trial #Rare disease

Positive initial data on first mRNA therapy for propionic acidemia

Moderna has reported encouraging interim data from its Phase I/II trial of mRNA-3927, an mRNA therapy for rare metabolic disorder propionic acidemia (PA). The data was presented at the 2023 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting. The ongoing global Phase… Read More

#News #Trending News

#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene therapy

Under the microscope: Zoning in on the CGT sector

Listen to this article on the DDW Podcast: IB Communications’ CEO Michelle Boxall explains why there are two sides to the cell and gene therapy coin. Charles Dickens’ quote, “It was the best of times, it was the worst of times”, aptly describes the complexity surrounding CGT… Read More

#Exclusive Content #Opinion

#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene therapy

Understanding the future roadmaps of cell and gene therapy

Listen to this article on the DDW Podcast: DDW’s Megan Thomas caught up with George White, General Manager, Product Management, Cell & Gene Therapy at Cytiva, to learn more about the company’s insight into the CGT market. Key challenges for cell and gene therapies In order for cell… Read More

#Exclusive Content #Opinion

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Gene therapy

No sign of stopping: The rise of cell and gene therapy

Listen to this article on the DDW Podcast: Ryan Leahy, a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. While the global economic landscape faces a major… Read More

#Exclusive Content #Opinion

#Advanced Therapies #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #GMP #Whitepaper

New whitepaper: Take a deep dive into cell therapy

Cell therapy research has never been more exciting with all of the research ongoing. Download this new white paper ‘Diving deep into cell therapy: An industry perspective’ to find out more. Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy… Read More

#News

ACROBiosystems DDW white paper
#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #GMP

Diving deep into cell therapy: An industry perspective

Cell therapy research has never been more exciting with all of the research ongoing. Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell… Read More

#Resources

Cell and gene therapies
#Advanced Therapies #Cell and gene therapy #Cell and Gene Therapy Catapult

New CGT process analytical technologies lab opens

The Cell and Gene Therapy Catapult (CGT Catapult) has opened a new laboratory in Stevenage, UK, which has been specifically designed and equipped to allow cell and gene therapy (CGT) developers to monitor and control their advanced therapy manufacturing processes in real-time, to improve product quality and safety while… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell culture #Drug development #Drug discovery #Whitepaper

Whitepaper: From bench to billions in cell and gene therapy

Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies’, brought you by Corning. Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell culture #Drug development #Drug discovery

From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies

Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more challenging when the cells of interest are attachment-dependent, such as induced pluripotent stem cells (iPSCs). The choice of cell culture platform will have significant operational… Read More

#Resources

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

Keep up to date: DDW Highlights 30 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Cell and gene therapies have been making the news this week, as… Read More

#News

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

This week in drug discovery (23-27 January)

News round-up for 23-27 January by DDW Digital Content Editor Diana Spencer. Cell and gene therapies have been making the news this week, as we launch our very own guide to global… Read More

#News

#Advanced Therapies #Cell and gene therapy

Reflections from Advanced Therapies Week 2023 

Over the three days of Advanced Therapies Week (ATW) 2023 in Miami, Florida, US, from 18 to 20 January, DDW’s Megan Thomas heard from attendees about what they were most looking forward to learning from the event, as well as why they think the potential of cell and gene… Read More

#Exclusive Content #Opinion

#Advanced Therapies #Cell and gene therapy

Cell and gene therapies: Opportunities for innovation 

Listen to this article on the DDW Podcast: By Dr. Deborah Phippard, Chief Scientific Officer of Precision for Medicine and Anshul Mangal, President & General Counsel of Project Farma.  In recent years the advanced therapy industry has been the most significant disruptor in medicine. Cell and gene therapies… Read More

#Exclusive Content #Opinion